Document Type
Article
Publication Date
12-19-2025
Original Citation
Coscarella I,
Usman O,
Wang L,
Landim-Vieira M,
Wirstiuk L,
Brown A,
Zorio D,
Washburn B,
Vied C,
Knollmann B,
Solís C,
Galkin V,
Chase P,
Hinson J,
Irianto J,
Pinto J.
Phenotype specific nuclear lamina remodeling in hiPSC derived cardiomyocytes bearing iScience. 2025;28(12):113901
Keywords
JGM
JAX Source
iScience. 2025;28(12):113901
ISSN
2589-0042
PMID
41321620
DOI
https://doi.org/10.1016/j.isci.2025.113901
Grant
HL165220 (to J.T.H.),
Abstract
Cardiomyocytes endure physical stress from the myocardium environment while generating their own mechanical strains. The force generated by sarcomeres is transmitted both longitudinally to adjacent sarcomeres and laterally to the cytoskeleton via intermediate filaments. This mechanical stimulus impacts other organelles, including the nucleus, thus playing a vital role in sensing and signaling nuclear adaptations. However, there is limited understanding of how changes in cardiac contractility affect nuclear mechanics. Here, we sought to investigate the effects of hyper- and hypo-contractility in nuclei of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) bearing TNNT2 pathogenic variants associated with hypertrophic (HCM) or dilated (DCM) cardiomyopathies. Transcriptomics analyses of these variant bearing hiPSC-CMs confirmed that differential gene expression occurs and is associated with maladaptive and compensatory responses in HCM and DCM. Our findings show a cause-and-effect link between impaired contractility and nuclear lamina remodeling in cardiomyopathic phenotypes. Disease-induced dysfunctional contractile transients alter the expression of nucleoskeleton protein lamin A/C, influencing nuclear stiffness. These changes in stiffness were rescued by treatment with myosin modulators Mavacamten or Omecamtiv Mecarbil. This study shows that nuclear mechanics is influenced by the interaction between the sarcomere and the cytoskeletal network. Exploring the relationship between contractile dysfunction and nuclear lamina remodeling may reveal new therapeutic targets for cardiomyopathies.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.